Table 5.

The Effect of miR-3609 on Sorafenib’s Antitumor Effect on HCC Cells’ Subcutaneous Growth

Cell Lines	Control	miR-3609	miR-3609 + EPAS-1Mut
	IC50 values of Soarfenib on Subcutaneous Tumor Weights (mg/kg)
MHCC97-H	2.25±0.44	0.15±0.02	2.51±0.52
PDC No. 1	~3	0.87±0.39	>3
PDC No. 2	1.77±0.20	0.48±0.10	2.20±0.45
PDC No. 3	1.99±0.54	0.30±0.04	1.81±0.41
PDC No. 4	2.70±0.70	0.95±0.60	2.76±0.62
PDC No. 5	2.88±0.39	0.66±0.21	2.32±0.69